For localized information and support, would you like to switch to your country-specific website for {0}?
Overview
From uncovering patient-specific disease mechanisms to quantifying drugs and biomarkers, mass spectrometry has become an essential clinical tool—yet embedding its analytical accuracy into routine practice demands technical innovation, robust validation, and European in vitro diagnostic regulation (IVDR) compliance.
To address these challenges, the 1st INCAMS meeting convenes from 11–13 December 2026 in Rimini, Italy, bridging the gap between research innovation and clinical routine. Across three days, international users, researchers, and experts will share innovative practical strategies, and establish a global network dedicated to advancing mass spectrometry in clinical care.1
Roche Diagnostics at INCAMS 2026
As a scientific partner and sponsor of the 1st INCAMS Meeting, Roche Diagnostics is dedicated to advancing clinical mass spectrometry testing to broaden access to new diagnostic capabilities for patients.
We invite you to attend our industry workshop, "The evolution of mass spectrometry in therapeutic drug monitoring: Advancing clinical value, laboratory performance, and sustainability."
In this session, clinical and health economics leaders will share insights on critical patient management alongside independent Health Technology Assessment (HTA) evidence on our cobas® Mass Spec solution. Browse the full agenda below to explore session details.
Let’s explore together how automated mass spectrometry empowers laboratories to optimize operations, improve patient outcomes, and stay ahead of new dimensions.
References
- INCAMS. Preliminary programme [Internet; cited 2026 Nov 12]. Available from: https://www.incamsmeeting.org/#!/up
- ALTEMS Advisory. Health Technology Assessment di cobas® Mass Spec Solution: Analisi Organizzativa ed Economica per l’integrazione nei Laboratori Clinici. [Internet; cited 2026 Nov 12]. Available from: https://www.altemsadvisory.com/health-technology-assessment-di-cobas-mass-spec-solution-analisi-organizzativa-ed-economica-per-lintegrazione-nei-laboratori-clinici/